Tricida Inc. [TCDA] moved down -10.93: Why It’s Important

Tricida Inc. [NASDAQ: TCDA] stock went on a downward path that fall over -10.93% on Friday, amounting to a one-week price decrease of less than -96.48%. The company report on October 24, 2022 that Tricida Reports Topline Results from the VALOR-CKD Phase 3 Trial of Veverimer.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Webcast today at 8:00 am Eastern Time.

Tricida, Inc. (NASDAQ: TCDA) announced today the top-line results from its VALOR-CKD renal outcomes clinical trial, designed to evaluate veverimer’s ability to slow CKD progression in patients with metabolic acidosis and chronic kidney disease (CKD).

Over the last 12 months, TCDA stock dropped by -91.66%. The average equity rating for TCDA stock is currently 2.20, trading closer to a bullish pattern in the stock market.

The market cap for the stock reached $23.90 million, with 57.83 million shares outstanding and 51.02 million shares in the current float. Compared to the average trading volume of 3.86M shares, TCDA stock reached a trading volume of 17027306 in the most recent trading day, which is why market watchdogs consider the stock to be active.

Guru’s Opinion on Tricida Inc. [TCDA]:

Goldman have made an estimate for Tricida Inc. shares, keeping their opinion on the stock as Buy, with their previous recommendation back on April 13, 2022. The new note on the price target was released on November 16, 2021, representing the official price target for Tricida Inc. stock. Previously, the target price had yet another raise to $8, while JP Morgan analysts kept a Underweight rating on TCDA stock. On August 25, 2020, analysts decreased their price target for TCDA shares from 25 to 10.

TCDA Stock Performance Analysis:

Tricida Inc. [TCDA] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -96.48. With this latest performance, TCDA shares dropped by -96.17% in over the last four-week period, additionally sinking by -95.85% over the last 6 months – not to mention a drop of -91.66% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TCDA stock in for the last two-week period is set at 19.27, with the RSI for the last a single of trading hit 14.72, and the three-weeks RSI is set at 23.17 for Tricida Inc. [TCDA]. The present Moving Average for the last 50 days of trading for this stock 10.2709, while it was recorded at 0.4865 for the last single week of trading, and 9.7797 for the last 200 days.

Insight into Tricida Inc. Fundamentals:

Return on Equity for this stock declined to -323.71, with Return on Assets sitting at -67.89.

Tricida Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.10 and a Current Ratio set at 5.10.

Tricida Inc. [TCDA] Insider Position Details

There are presently around $17 million, or 89.00% of TCDA stock, in the hands of institutional investors. The top three institutional holders of TCDA stocks are: ORBIMED ADVISORS LLC with ownership of 10,280,947, which is approximately 0% of the company’s market cap and around 8.39% of the total institutional ownership; VR ADVISER, LLC, holding 7,132,079 shares of the stock with an approximate value of $2.73 million in TCDA stocks shares; and DEEP TRACK CAPITAL, LP, currently with $1.05 million in TCDA stock with ownership of nearly 2.994% of the company’s market capitalization.

Positions in Tricida Inc. stocks held by institutional investors increased at the end of November and at the time of the November reporting period, where 74 institutional holders increased their position in Tricida Inc. [NASDAQ:TCDA] by around 8,319,332 shares. Additionally, 48 investors decreased positions by around 6,763,712 shares, while 14 investors held positions by with 29,243,600 shares. The mentioned changes placed institutional holdings at 44,326,644 shares, according to the latest SEC report filing. TCDA stock had 42 new institutional investments in for a total of 1,500,151 shares, while 18 institutional investors sold positions of 2,478,866 shares during the same period.

LEAVE A REPLY

Please enter your comment!
Please enter your name here